Three rising stars you’ll wish you bought in 10 years. Key Points Poshmark is in the driver’s seat of a booming market for secondhand clothing. People will still buy pet supplies from Chewy during a market downturn. Lululemon Athletica is changing the way people shop for fitness clothing. Whether you’re a seasoned investor or just getting started, it’s never fun…
The United States Department of Energy has just published their “blueprint” for a huge increase in the use of solar power in the USA from 4% to 45% of the total energy budget. This got us wondering how to profit from the growth of solar energy over the next years and decades. The work necessary to achieve this goal by…
Biotech ETFs offer diversified, low-cost exposure. If anyone didn’t already understand the dynamic potential of the health care sector, the pandemic has proven in real time how innovative the next generation of pharmaceutical companies are – and how vital they are to public health. So-called “biotechnology” companies look beyond chemical compounds or surgical tools to harness the power of biological systems…
Technology stocks resumed their bullish momentum in the Spring as the Technology Select Sector SPDR Fund (XLK) has gained 19.6% since May 12th. While investors can’t predict how long this current run will last for tech stocks, a great way to limit your losses is to focus on highly profitable tech stocks. Picking high-profit stocks can lead to substantial gains. …
Looking for more opportunities to make money on a trade? Then consider pairs trading, which, as today’s article explains, “gives you several opportunities to make money on a trade, even if the original thesis doesn’t pan out as expected”. For a guide to pairs trading — including what it is, the benefits and drawbacks of this type of trade, and…
In today’s article, the author shares what he considers to be “the best stocks in the best industries.” Those industries, in his view? Internet, footwear and specialty finance. For what he deems to be the best stocks from those three industries, CLICK HERE.
When it comes to a stock’s Relative Strength (RS) Rating, the author of today’s article notes that “History shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they launch their biggest climbs.” The life sciences company he highlights just had its RS Rating upgraded from 80 to 89,…
Earlier this year, the biotech company featured in today’s article was a penny stock. But after uplisting to the Nasdaq, the author of today’s article notes that “it has been making big moves in the market and moving some of Wall Street’s top analysts to set initial targets over $20 right now.” For more on how this company’s approach to…
“In a world where interest rates are so low and uncertainty seems to be the norm, baby boomers need to look for stable dividend stocks that can compete with the current income of longer-term Treasury notes “Favorable government regulations, coupled with the introduction of new and sophisticated products, and growing demand for synthetic biology, should keep driving the biotech industry’s…
The author of today’s article advises that “before investing in a biotech company, it’s essential to look at the financial opportunity offered by its current lineup of products (or most promising pipeline candidates), both in the short and long run.” With that, they proceed to highlight two biotech stocks that could be top picks right now based on the great…